The CiRA iPSC Story In Search of New Drugs - An Open Lab

In the 2nd part of our 2-part series on CiRA, we focus on iPS cell-based research into incurable diseases such as ALS and muscular dystrophy, and the progress of drug development. We also take a look at CiRA's ethics research division. What's that, you ask? It reflects Nobel-prize winning Prof. Yamanaka's comprehensive approach to the double-edged sword of scientific development. Tune in to see internal meetings and much more, behind the scenes at this innovative research institution.